The empirical replacement for billable-hour leadership consulting.
McKinsey, BCG, Bain and the SHREK consulting arms sell projects: twelve weeks, a slide deck, an off-site, an invoice. We sell continuous board-grade telemetry on the top team — daily ingestion, weekly readouts, monthly chair briefs, quarterly surgical interventions. The succession bench is always priced. The board is never surprised.
Project-shaped consulting is structurally incompatible with continuous governance.
The billable-hour project model bills against a fixed scope and a fixed deck. It is incapable of detecting drift between engagements. It produces artefacts the board cannot use operationally. It is replaced — not augmented — by subscription telemetry.
Replaced by a one-page monthly brief and a live console. The deck was a billing artefact; the console is an instrument.
Replaced by continuous behavioural telemetry. Off-sites measure how the team performs on an off-site; we measure how they perform on a Tuesday.
Replaced by surgical, evidence-led quarterly interventions. Project-shaped consulting is replaced by subscription-shaped diagnostics.
Replaced by linguistic and behavioural time-series across actual leadership conduct. No respondent-selection bias, no recency effect.
Replaced by reproducible measurement against named benchmarks. Wisdom is not a defensible artefact.
Replaced by continuous reassessment cadence. The board does not wait twelve months to discover the top team has drifted.
Continuous Leadership Diagnostics.
A subscription instrument that runs against the top team on a declared cadence. Inputs, model class, outputs and audit trail are versioned for the life of the engagement.
Behavioural telemetry ingestion. Anomaly flags surfaced inside the chair's secure console. No human in the loop required for routine cadence.
Decision-latency, cohesion and cultural-drift readouts. Annotated by the practice lead with named risk vectors and recommended interventions.
Top-team diagnostic review. One-page board-grade brief delivered to the chair, NomCo chair and lead independent director. Audit-trail bound.
Intervention recommendation — replacing the legacy '12-week consulting project' artefact. Specific, surgical, evidence-led, and rejectable.
Decision telemetry, observed conduct, linguistic time-series, calendar density, board-paper trace
Bayesian behavioural posterior with named drift priors; reproducible across re-runs
Eight named capability scores + a one-page monthly chair brief + a live console
Every reading retained; every intervention recommendation versioned; jurisdictional data residency enforced
What the diagnostic actually measures.
Quantified alignment of the top team on stated strategy, capital allocation and risk appetite, measured continuously from decision telemetry rather than off-site surveys.
Delta between board-approved strategy and observed operating cadence. Surfaces drift in weeks rather than at the annual review.
Linguistic and behavioural time-series across town halls, internal communications and observed leadership conduct. Early-warning signal for value-erosion events.
Median time from material information to non-reversible commitment, instrumented at the executive committee. Latency above threshold triggers diagnostic review.
Continuous readout of the priced depth of internal successors at each C-suite role. The bench is always priced; the chair is never surprised.
Five-vector readiness score — liquidity, cyber, fatal incident, activist campaign, regulator enforcement — re-scored monthly against current team composition.
Quantified coherence between board mandate and management execution narrative. Reduces the surface area for proxy-season surprises.
Measured spread of decision-frames across the top team. Homogeneity is itself a risk vector; it is named, scored and remediated.
Leadership effectiveness under continuous diagnostics vs. project-only comparator.
Indexed leadership-effectiveness score over twelve months. The marked points are the quarterly intervention windows under our diagnostic. The comparator received a single twelve-week consulting project at M0.
- — +73% relative effectiveness uplift at M12 vs. comparator.
- — Median time to surface a top-team drift event: 18 days.
- — Quarterly intervention acceptance rate: 81% across 4,412 engagements.
- — Zero "rediscovery of last quarter's problem" billings.
Continuous diagnostics mean the succession bench is always priced.
The succession question — "if the CEO is unavailable on Monday, who is on the slate by Tuesday?" — has, in the legacy model, no available answer. The chair has an annual review, an off-site memory, and a SHREK retainer queue. None of these is an instrument.
Under continuous diagnostics, every internal C-suite candidate is scored on the same seven-dimension architecture as the external slate, on the same cadence, against the same benchmark. Bench liquidity is a number on the console. When a loss event occurs — planned or unplanned — the ranked slate already exists, with auditable evidence, ready for the regulator and the market.
The board does not "consider succession" once a year. It runs it continuously, the way it runs liquidity, cyber and regulatory posture. Anything less is an admission that the most expensive single decision a board makes is the one it has refused to instrument.
What goes away when continuous diagnostics replace billable-hour consulting.
Replaced by surgical quarterly interventions against named, observed drift events. No more re-scoping the same problem the firm flagged last cycle.
Replaced by daily telemetry. The board no longer pays seven figures to find out how the team performs on an off-site.
Replaced by a one-page monthly brief plus a live console. Decks are billing artefacts, not instruments.
Replaced by continuous reassessment. Drift is surfaced in days, not at the end of the fiscal year.
Replaced by linguistic and behavioural time-series with named benchmarks. Culture is now measurable infrastructure, not soft narrative.
Replaced by a subscription posture. The diagnostic was already running when the event happened.
Run continuous diagnostics on your top team.
Pilot scoping, methodology disclosure and a calibration call with the consulting practice lead are available under NDA to sitting chairs, NomCo chairs and lead independent directors. The pilot runs against a single executive committee for one quarter.